1 Comment
⭠ Return to thread

Hi all, thank you for your replies. May I point out that we are all here in general agreement about our suspicious re: trans ideology? However, it is indisputable that Jennifer Bilek has promoted Keith Woods, who links some nefarious "transhumanism" project to Judaism itself, and who has promoted some pretty vile racist ideology on Youtube and various social medial platforms. As to the objection that "some of the billionaires are in fact Jewish," well, OK, but when you name only Soros, Pritzker, Rothblatt, etc, AND you link to known white supremacists, I'm going to say that's not somebody I'm inviting to my son's bar mitzvah. (She also names the Stryker family, not clear if they are Jewish but apparently lots of people who don't like them say they are, which could be false, not sure, so let's call that a wash.)

I'm sure Bilek is right about many things, and I agree that environmentalism and gender-critical viewpoints have strong connections. If calling her a frothing anti-Semite was over the top, fine, I retract is and will restate: she has many insights into the promotion of trans ideology AND she's promoted the work of known anti-Semites/ white supremacists AND some of her work is perceived as crossing the bounds into stereotypes of Jewish power and money.

Re: bioethics apologism. I've been on a hospital IRB for 7 years and have reviewed dozens of applications and consent forms. All I said was, it's a little more complicated than corrupt IRB's and I also said there's a backlash brewing against woke bioethics, which is really a thing.

In other words, we can disagree about Bilek- who still isn't invited to my son's bar mitzvah- but I'm on this blog because I agree with much of what's been written here and have, in the hospital setting, seen some of these things play out in real time. Medical research has many overlapping rules and regulatory agencies and policies and procedures, everything that Eliza wrote may be true under some circumstances and it's still complicated to get bad or ineffective drugs to market. Once they are approved for something- anything- it's much easier to promote drugs for off-label uses.

Expand full comment